Whereas genes with decreased expression (ARID1A KO vs WT) were relevant to cancer pathways, including cell adhesion molecules, Type 1 Diabetes Mellitus, toxoplasmosis (Figure 1C). This evidence concerns the gene ARID1A and cancer.